KIA-Korekt: Staged Unimodal-to-Multimodal AI Evaluation for Perioperative Risk Prediction in Colorectal Cancer

Recruiting Observational Study
Colorectal Cancer Postoperative Complications
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
910 (estimated)
Sponsor
Rene Mantke · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Perioperative complications following surgery for colorectal cancer (CRC) represent a major cause of postoperative morbidity and mortality. Existing risk stratification tools lack the precision to capture the complex biological and morphological factors that determine individual patient vulnerability. Artificial intelligence (AI)-based analysis of medical imaging data offers a promising approach t…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Adult patients (≥18 years) * Histologically confirmed colorectal adenocarcinoma * Undergoing surgical resection (curative or palliative intent) * Availability of H\&E-stained whole-slide images (WSIs) from the primary tumour Exclusion Criteria: * Patients not undergoing surg…
Contacts

Melissa Horner, MSc

+4915207809673

melissa.schadl@mhb-fontane.de

CONTACT